January 22, 2013Drugs/Medicineadmin Galectin Therapeutics , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced new preclinical data on the efficacy of anti-galectin therapy on diabetic kidney disease.
